PROC logo

Procaps Group, S.A. Ordinary Shares


PROC: Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.


Show PROC Financials

Consumer Interest
SEC Filings

Recent trades of PROC by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by PROC's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Extracts of Apr. 06, 2021
  • Patent Title: Method and apparatus for printing on soft gelatin capsules during forming Jun. 03, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of PROC in WallStreetBets Daily Discussion


Recent insights relating to PROC

CNBC Recommendations

Recent picks made for PROC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PROC

Corporate Flights

Flights by private jets registered to PROC